Literature DB >> 16723978

New insights into cystic fibrosis: molecular switches that regulate CFTR.

William B Guggino1, Bruce A Stanton.   

Abstract

Cystic fibrosis transmembrane conductance regulator (CFTR), a Cl(-)-selective ion channel, is a prototypic member of the ATP-binding cassette transporter superfamily that is expressed in several organs. In these organs, CFTR assembles into large, dynamic macromolecular complexes that contain signalling molecules, kinases, transport proteins, PDZ-domain-containing proteins, myosin motors, Rab GTPases, and SNAREs. Understanding how these complexes regulate the intracellular trafficking and activity of CFTR provides a unique insight into the aetiology of cystic fibrosis and other diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16723978     DOI: 10.1038/nrm1949

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  183 in total

1.  Contribution of casein kinase 2 and spleen tyrosine kinase to CFTR trafficking and protein kinase A-induced activity.

Authors:  Simão Luz; Patthara Kongsuphol; Ana Isabel Mendes; Francisco Romeiras; Marisa Sousa; Rainer Schreiber; Paulo Matos; Peter Jordan; Anil Mehta; Margarida D Amaral; Karl Kunzelmann; Carlos M Farinha
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

Review 2.  Update on the mechanisms of gastric acid secretion.

Authors:  Sascha Kopic; John P Geibel
Journal:  Curr Gastroenterol Rep       Date:  2010-12

3.  PDZK1 binding and serine phosphorylation regulate subcellular trafficking of organic anion transport protein 1a1.

Authors:  Jo H Choi; John W Murray; Allan W Wolkoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-23       Impact factor: 4.052

4.  Serum- and glucocorticoid-induced protein kinase 1 (SGK1) increases the cystic fibrosis transmembrane conductance regulator (CFTR) in airway epithelial cells by phosphorylating Shank2E protein.

Authors:  Katja Koeppen; Bonita A Coutermarsh; Dean R Madden; Bruce A Stanton
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

5.  AP2 α modulates cystic fibrosis transmembrane conductance regulator function in the human intestine.

Authors:  Vandana Kumari; Shruti Desai; Nadia A Ameen
Journal:  J Cyst Fibros       Date:  2017-04-21       Impact factor: 5.482

Review 6.  From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking.

Authors:  Carlos M Farinha; Sara Canato
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

Review 7.  Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator.

Authors:  Daniella Muallem; Paola Vergani
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-01-27       Impact factor: 6.237

Review 8.  Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.

Authors:  James L Kreindler
Journal:  Pharmacol Ther       Date:  2009-11-10       Impact factor: 12.310

9.  Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules.

Authors:  Owen M Woodward; Deepali N Tukaye; Jinming Cui; Patrick Greenwell; Leeza M Constantoulakis; Benjamin S Parker; Anjana Rao; Michael Köttgen; Peter C Maloney; William B Guggino
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

10.  AC6 is the major adenylate cyclase forming a diarrheagenic protein complex with cystic fibrosis transmembrane conductance regulator in cholera.

Authors:  Andrew Thomas; Yashaswini Ramananda; KyuShik Mun; Anjaparavanda P Naren; Kavisha Arora
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.